StockData

Lexicon Pharmaceuticals vs SIGA Technologies

LXRX and SIGA side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How LXRX and SIGA compare

Lexicon Pharmaceuticals is the larger company, worth 4.0 times as much as SIGA Technologies ($792M against $196M).

Lexicon Pharmaceuticals grew revenue faster over the last twelve months (−29.0% versus −70.1% for SIGA Technologies).

SIGA Technologies keeps more of each dollar of sales as profit, with a net margin of −5.2% compared with −147% at Lexicon Pharmaceuticals.

SIGA Technologies pays a dividend yielding 22.0%; Lexicon Pharmaceuticals does not pay one.

SIGA Technologies scores higher on the StockData Score (14 against 5 for Lexicon Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricLXRXSIGA
Size and price
Market cap$792M$196M
Share price$1.78$2.73
Change, 1 year19.5%−54.5%
Change, 5 years−62.4%−68.0%
Beta (5Y)0.010.49
Employees8149
StockData Score
Total score514 (better)
Valuation score03 (better)
Growth score1 (better)0
Performance score22
Health score26 (better)
Dividend score03 (better)
Valuation
P/S19.1×3.7× (better)
P/B4.5×1.2× (better)
Fair value$0.950$7.43
Margin of safety−87.4%63.2% (better)
Growth
Revenue growth (TTM)−29.0% (better)−70.1%
Revenue growth, 5Y average15.7% (better)−5.4%
Net income growth (TTM)–−103%
EPS growth (TTM)–−104%
EPS growth, 5Y average–−14.7%
Profitability
Gross margin99.1% (better)54.4%
Operating margin−131%−20.8% (better)
Net margin−147%−5.2% (better)
Return on equity−40.2%−1.5% (better)
Return on invested capital−163%−23.6% (better)
Financial health
Debt / equity0.29 (better)0.00
Current ratio13.3721.72 (better)
Altman Z-score−4.8711.85 (better)
Piotroski F-score46 (better)
Dividends and buybacks
Dividend yield–22.0%
Years of dividend growth–0
Shareholder yield0.00%22.0% (better)
Ownership
Held by institutions81.9%48.5%
Held by insiders–1.9%
Insider net buying, 12 months$2.8M–
Short interest, % of float–5.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.